Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.
BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 mo...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
_version_ | 1826261211526725632 |
---|---|
author | Blanchard-Rohner, G Snape, MD Kelly, D O'Connor, D John, T Kibwana, E Parks, H Ford, K Dull, P Pollard, A |
author_facet | Blanchard-Rohner, G Snape, MD Kelly, D O'Connor, D John, T Kibwana, E Parks, H Ford, K Dull, P Pollard, A |
author_sort | Blanchard-Rohner, G |
collection | OXFORD |
description | BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 months of age on the immune response to a primary course of quadrivalent meningococcal conjugate vaccine (MenACWY-CRM197) given at 2 and 4 months of age. METHODS: This was a single-center, open-label, randomized study undertaken in Oxford, United Kingdom. Two hundred sixteen healthy infants were enrolled in the study and vaccinated with MenACWY-CRM197 at 2 and 4 months of age. Blood was obtained from all mothers, in a subset of infants at 2 months and all infants at 5 months. Antibody and memory B-cell responses at 5 months were correlated with maternal antibodies. RESULTS: Mothers had low IgG antibodies against serogroups C, W135 and Y polysaccharides, but high serogroup A antibody, whereas 61-78% had protective human complement serum bactericidal activity (hSBA) (≥1:4) for serogroups C, W135 and Y but only 31% for serogroup A. Only 9%, 32%, 45% and 19% of 2-month-old infants had hSBA ≥1:4 for serogroups A, C, W135 and Y, respectively. Maternal antibody had little association on responses to MenACWY-CRM197, except a moderate negative association between MenC-specific bactericidal antibody at 2 and 5 months (r = -0.5, P = 0.006, n = 28) and between carrier-specific IgG antibody at 2 months and MenC-specific hSBA/IgG antibody at 5 months (r = -0.4, P = 0.02 and 0.04, n = 32 and 23). Nonetheless, 90% of infants achieved protective MenC-hSBA titers after vaccination at 2 and 4 months of age. CONCLUSIONS: The levels of serogroup-specific meningococcal antibodies were low in mothers and 2-month-old infants. Immunizing mothers before or during pregnancy with meningococcal conjugate vaccines might increase antibody levels in early infancy and provide protection against infection due to N. meningitidis. |
first_indexed | 2024-03-06T19:17:57Z |
format | Journal article |
id | oxford-uuid:1910cc9d-6fd8-4abe-a13c-af7acd5979f5 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T19:17:57Z |
publishDate | 2013 |
record_format | dspace |
spelling | oxford-uuid:1910cc9d-6fd8-4abe-a13c-af7acd5979f52022-03-26T10:46:51ZSeroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1910cc9d-6fd8-4abe-a13c-af7acd5979f5EnglishSymplectic Elements at Oxford2013Blanchard-Rohner, GSnape, MDKelly, DO'Connor, DJohn, TKibwana, EParks, HFord, KDull, PPollard, A BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 months of age on the immune response to a primary course of quadrivalent meningococcal conjugate vaccine (MenACWY-CRM197) given at 2 and 4 months of age. METHODS: This was a single-center, open-label, randomized study undertaken in Oxford, United Kingdom. Two hundred sixteen healthy infants were enrolled in the study and vaccinated with MenACWY-CRM197 at 2 and 4 months of age. Blood was obtained from all mothers, in a subset of infants at 2 months and all infants at 5 months. Antibody and memory B-cell responses at 5 months were correlated with maternal antibodies. RESULTS: Mothers had low IgG antibodies against serogroups C, W135 and Y polysaccharides, but high serogroup A antibody, whereas 61-78% had protective human complement serum bactericidal activity (hSBA) (≥1:4) for serogroups C, W135 and Y but only 31% for serogroup A. Only 9%, 32%, 45% and 19% of 2-month-old infants had hSBA ≥1:4 for serogroups A, C, W135 and Y, respectively. Maternal antibody had little association on responses to MenACWY-CRM197, except a moderate negative association between MenC-specific bactericidal antibody at 2 and 5 months (r = -0.5, P = 0.006, n = 28) and between carrier-specific IgG antibody at 2 months and MenC-specific hSBA/IgG antibody at 5 months (r = -0.4, P = 0.02 and 0.04, n = 32 and 23). Nonetheless, 90% of infants achieved protective MenC-hSBA titers after vaccination at 2 and 4 months of age. CONCLUSIONS: The levels of serogroup-specific meningococcal antibodies were low in mothers and 2-month-old infants. Immunizing mothers before or during pregnancy with meningococcal conjugate vaccines might increase antibody levels in early infancy and provide protection against infection due to N. meningitidis. |
spellingShingle | Blanchard-Rohner, G Snape, MD Kelly, D O'Connor, D John, T Kibwana, E Parks, H Ford, K Dull, P Pollard, A Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title | Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title_full | Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title_fullStr | Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title_full_unstemmed | Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title_short | Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom. |
title_sort | seroprevalence and placental transmission of maternal antibodies specific for neisseria meningitidis serogroups a c y and w135 and influence of maternal antibodies on the immune response to a primary course of menacwy crm vaccine in the united kingdom |
work_keys_str_mv | AT blanchardrohnerg seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT snapemd seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT kellyd seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT oconnord seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT johnt seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT kibwanae seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT parksh seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT fordk seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT dullp seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom AT pollarda seroprevalenceandplacentaltransmissionofmaternalantibodiesspecificforneisseriameningitidisserogroupsacyandw135andinfluenceofmaternalantibodiesontheimmuneresponsetoaprimarycourseofmenacwycrmvaccineintheunitedkingdom |